High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1-Reference-Cited by-同舟云学术

High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1

Published:2020-12 Issue: Volume:141 Page:193-198
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Muñoz-Unceta Nerea,Zugazagoitia Jon,Manzano Arancha,Jiménez-Aguilar Elisabeth,Olmedo María E.,Cacho Juan D.,Oliveira Julio,Dómine Manuel,Ortega-Morán Laura,Aguado Carlos,Luna Ana M.^ORCID,Fernández Lourdes,Pérez Javier,Font Carme,Salvador Carmen,Corral Jesús,Benítez Gretel,Ros Silverio,Biosca Mercedes^ORCID,Calvo Virginia,Martínez Julia,Sánchez-Cánovas Manuel,López Rafael,Sereno María,Mielgo Xabier,Aparisi Francisco,Carmona Marta,Carrión Rafael,Ponce-Aix Santiago,Soares Marta,Martínez-Salas Imanol,García-Morillo Marcial,Juan-Vidal Oscar,Blasco Ana,Muñoz Andrés J.,Paz-Ares Luis

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference14 articles.

1. Venous thromboembolism in cancer patients: an underestimated major health problem;Khalil;World J Surg Oncol,2015

2. Approaches to risk-stratifying cancer patients for venous thromboembolism;Khorana;Thromb Res,2007

3. A validated risk score for venous thromboembolism is predictive of cancer progression and mortality;Kuderer;Oncol,2016

4. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma;Blom;J Thromb Haemostasis,2004

5. Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer;Zugazagoitia;Eur Respir J,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS1-rearranged non-small cell lung cancer: Understanding biology and optimizing management in the era of new approvals;Current Problems in Cancer;2024-12

2. Impact of COVID-19 in the incidence of venous thromboembolism (VTE) and clinical outcomes in cancer patients: a cohort study;Clinical and Translational Oncology;2024-08-02

3. Importance of Testing for ROS1 Rearrangements in Non-Small Cell Lung Cancer in the Era of Targeted Therapy in a Latin American Country;Cancer Management and Research;2024-07

4. Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation;Journal of Oncology Pharmacy Practice;2024-04-05

5. Changing profile of lung cancer clinical characteristics in China: Over 8-year population-based study;Chinese Medical Journal Pulmonary and Critical Care Medicine;2023-09